Delivery Order SPE2DB22D3016-SPE2DB25FAZG4

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,973.82, is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, over the period ending on May 8, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,579.87 and is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a period of performance through January 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $2,789.97 and a completion date of May 22, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,786.07 fixed-price contract is for the delivery of the drug BRIVIACT 100 MG TABLET 60S. The contract has a performance period through June 12, 2025 and is not a set-aside. AmerisourceBergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,104.87, is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance ending on February 5, 2025. The contract was not set aside for any particular business type. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,875.96, is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price, delivery order contract with a completion date of February 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,579.94, is for the supply of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025, and is a firm fixed-price delivery order contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor in the U.S. The $1,716.20 firm-fixed-price contract is for the delivery of 4565907642 - BRIVIACT 75 MG TABLET 60S, a prescription medication. The contract has a period of performance through September 24, 2024 and does not utilize a small business set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRIVIACT 100 MG TABLET 60S, a specialty medication, with a ceiling value of $5,629.68 and a completion date of December 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.64 firm fixed price contract is for the delivery of 60 units of the drug BRIVIACT 100 MG TABLET. The contract has a performance period through June 13, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAZG4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,733.06, is for the delivery of BRIVIACT 50 MG TABLET 60S, a prescription medication. The contract has a firm fixed price pricing type and a period of performance through June 13, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is not designated as a set-aside.

Generated 9/11/25, 10:46 AM